Analysis Topic: Companies Analysis
The analysis published under this topic are as follows.
Friday, January 03, 2014
The Single-Best Graphene Investment Play on Earth / Companies / Graphene
By: Money_Morning
Michael A. Robinson writes: Imagine an “alternate reality” where it is possible to balance a Mack Bulldog tractor trailer on the sharpened tip of your No. 2 yellow pencil.
And imagine, also, that the tip of that same pencil is worth a small fortune.
This “reality” that I’m sketching out for you isn’t something that I grabbed from the plot of one of those cheesy Sci-Fi Channel late-night movies.
Read full article... Read full article...
Friday, January 03, 2014
Follow the Cardiovascular Medtech Stocks Merger and Acquisitions / Companies / Healthcare Sector
By: TLSReport
Some investors' eyes glaze over at the mention of medical devices. But it's time to wake up and focus on the stunning growth opportunities in small- and mid-cap cardiovascular medtech. Canaccord Genuity Managing Director Jason Mills covers companies on the front lines of innovation and in sectors where the trifecta of revenue, margins and reimbursement is achieving biotechlike levels. In this interview with The Life Sciences Report, Mills opens the new year with a discussion of the cardiovascular medtech industry and mentions companies that are probable acquisition candidates.
Tuesday, December 31, 2013
Time to Buy Out of Favour Stock ETF's Turkey, Gold, Brazil for 2014 ? / Companies / Investing 2014
By: David_Banister
The best time to buy cheap is when you are afraid to bring up your ideas around the water cooler at work for fear of the peer laughter. Our work centers on looking for oversold conditions and crowd behavioral anomalies that can give us better low risk entries with good upside potential. A combination of fundamentals and technical, combined with Elliott Wave Theory patterns can lead to nice profits with low risk.
For just a few quick ideas that would make sense in this area, we point out 3 ETF’s that you could look at entering now as they are way out of favor and very oversold.
Read full article... Read full article...
Monday, December 30, 2013
Facebook - Shot Across The Bow - RIP? / Companies / Tech Stocks
By: Michael_Noonan
One can never read tomorrow's news today, but developing market activity can give one a higher degree of probability as to what, if not tomorrow's then what the news will soon be sometime after. Facebook is a case in point. The Guardian ran an article on Friday, the 27th, giving an author's opinion that Facebook "is dead and buried to teens." If one were long that stock, the level of concern should run to high alert, for Facebook has no product, other than a social venue, and social "values" can change quickly, especially among teens.
Does a market send a message to exit from a position? We say a resounding Yes! There may be some room as to when, but if there is some kind of red flag alert, then one should have a set of rules in place to protect against potential adversity. Is Facebook sending such an alert? You be the judge.
Thursday, December 26, 2013
How Investors Can Profit From Battling Billionaires / Companies / Investing 2014
By: Money_Morning
Shah Gilani writes: Sure, the Herbalife game that pitted Bill Ackman against David Einhorn, Dan Loeb, Carl Icahn, and the rest of the billionaire boys' club was a tad bit personal.
It was also professional, very professional.
All the billionaires playing the Herbalife game are professional money managers. They made their mega fortunes in the markets.
Read full article... Read full article...
Thursday, December 26, 2013
Coming of Age: Experts Reflect on the Extraordinary Promise of the Cell Therapy Sector / Companies / BioTech
By: TLSReport
Without innovation and risk-taking, modern medicine would be missing staples of the physician's armamentarium: antibiotics, radiation therapies, vaccines. The idea of taking a tonic to cure what ails you is thousands of years old, but the science behind that tonic may be revolutionary. Enter stem cell technologies. Given the promise backing the science—and the sector's position on the cusp of breaking out—companies with cell therapies got plenty of attention from investment analysts and experts in 2013. Read what those experts, including George Zavoico of MLV & Co., Steve Brozak of WBB Securities, Jason Kolbert of the Maxim Group, and Kevin DeGeeter of Ladenberg Thalmann & Co., had to say about prospects for stem cell companies in this special retrospective article from The Life Sciences Report.
Tuesday, December 24, 2013
Surprising Way for investors to Participate in Today's Tech Boom / Companies / Tech Stocks
By: Frank_Holmes
If I asked you to name the biggest online shopping day of the year, what would you guess? Black Friday? Cyber Monday? Free Shipping Day in mid-December?
Guess again.
Even though Cyber Monday sales were spectacular this year, as online sales surged 20 percent and beat Black Friday receipts, the day didn't top November 11, Singles' Day in China. Singles' Day is a day of celebration for people who are single and has become popular among the young in China.
Read full article... Read full article...
Thursday, December 19, 2013
The Catastrophe Called Collapsing Corporate Earnings Growth / Companies / Corporate Earnings
By: Profit_Confidential
Michael Lombardi writes:
I keep telling you about my suspicion that the backbone of any stock market—corporate earnings growth—is disappearing. Now, we see it in the numbers…
Of the 106 companies in the S&P 500 that have issued corporate earnings guidance for the fourth quarter, an astounding 94 of them have issued negative guidance—that’s 89% of the companies issuing guidance, warning it will be negative, which is well above the five-year average rate of 63%. (Source: FactSet, December 13, 2013.)
Tuesday, December 17, 2013
This Is How You Win a Billionaires' Brawl - True Story / Companies / Corporate News
By: Money_Morning
Shah Gilani writes: There's a lucrative new trading "set-up" a lot of investors are using now. But unlike classic approaches, like "don't fight the Fed," and "the trend is your friend," there are no rules on how to play this new game.
So let's change that today.
This is the true story about two billionaires' egos, their trading games, and what happens when they clash over the same stock.
Read full article... Read full article...
Saturday, December 14, 2013
Cell Pouch System - Dramatic Diabetes Breakthrough in 2014? / Companies / Healthcare Sector
By: Richard_Mills
In a person with diabetes, the insulin producing beta cells in the pancreas are attacked by the immune system and destroyed, this leads to a deficiency of insulin and high blood sugar (glucose).
People with insulin-dependent diabetes (all of type-1 and about 27 percent of type-2 diabetics) lack the necessary amount of insulin in their bloodstreams. This can, and often does lead to irreversible damage to their hearts, blood vessels, eyes, kidneys, skin, feet and hearing.
Read full article... Read full article...
Friday, December 13, 2013
Growth Stocks that Could Outperform the Bull Market / Companies / Investing 2013
By: DailyGainsLetter
John Paul Whitefoot writes: When it comes to building a balanced portfolio, investors like to find stocks that provide both value and growth. If you’re a value investor, you’re always on the lookout for companies that are cheap relative to their earnings, assets, or price-to-book value; in other words, they look for what’s undervalued.
A growth investor, on the other hand, likes to look at publicly traded companies that are in a position to rapidly increase their revenues and profits; they want stocks with excellent long-term growth potential. This could include those stocks that have provided revenue and earnings guidance that is expected to outperform the market or industry.
Read full article... Read full article...
Friday, December 13, 2013
Biotech Growth Stocks Investing / Companies / BioTech
By: TLSReport
Get ready for a bonanza of biotech names. Managing Director and Equity Research Analyst Reni "Ren" Benjamin is a new arrival at H.C. Wainwright & Co., and he's busy doing diligence on a lot of stocks. Along with three Buy-rated biotechs he's already initiated coverage on, Benjamin brought The Life Sciences Report a bonus package of names that could fatten investors' portfolios. Backed by Benjamin's extensive industry knowledge, this long shopping list includes companies poised to make drug development history.
The Life Sciences Report: Do you currently have a major theme, Ren, or do you just go anywhere to find growth?
Read full article... Read full article...
Thursday, December 12, 2013
Investing to Win the $93 Billion Games Consoles War / Companies / Sector Analysis
By: Money_Morning
Michael A. Robinson writes: Thanks to two huge product rollouts in November, this holiday season will be one of the hottest ever for this massive slice of the high-tech sector.
That's because three giant companies are fighting it out - to the death - for the biggest piece of a $93 billion windfall.
And investors who identify the winner of this battle stand to pull down a hefty profit.
Read full article... Read full article...
Tuesday, December 10, 2013
Cool Science Tech for Your Health Training Workouts / Companies / Health and Fitness
By: John_Mauldin
I know that what you'll encounter in today's Outside the Box is not macroeconomics. But we all have to live in the real world, and our health is as real as it gets. So this is just one guy telling his friends about something he found that has helped make his world a lot better.
My friend and colleague Pat Cox is always finding something new and different. When Pat first introduced me to this idea, I thought he was being a little over the top. But I happened to be in Palo Alto the following week and met with the scientists Pat mentioned and saw their results. Then I got a beta unit and used it for the first time on my last birthday last year.
Read full article... Read full article...
Monday, December 09, 2013
Stock Market Forecast For 2014 / Companies / Stock Markets 2014
By: Money_Morning
Michael A. Robinson writes: If you’ve been following our twice weekly conversations here at Strategic Tech Investor, you know that I’m very bullish about technology stocks.
But I want to let you in on a little secret …
I’m also bullish about the overall stock market.
Read full article... Read full article...
Sunday, December 08, 2013
Rising Stock Market Does Not Lift All Stocks / Companies / Company Chart Analysis
By: Michael_Noonan
We advocate a proactive stance in managing one’s stock portfolio as the most
prudent way to preserve and grow capital, by capturing gains and limiting risks.
The days of buy and hold are finished, at this stage of a central bank propped-up
market, fed by fiat and highly questionable reports issued by the Bureau of Lies,
which seems an accurate assessment.
There are several charts to be shown, and where a picture may be worth 1,000 words, we can limit we say and defer to what the market has to say. After all, the market is the best source and always the final arbiter.
Read full article... Read full article...
Thursday, December 05, 2013
A Safe Way to Profit from China’s 700 IPOs to List in 2014 / Companies / China Stocks
By: InvestmentContrarian
George Leong writes: I pushed the “go” button on China a long time ago now, and I’m certainly not set to press “stop” yet, as I continue to feel the country is one of the top growth areas for investors worldwide. My contentions are contrary to those of many other analysts in the stock market, but I’m holding onto my bullish views.
Wednesday, December 04, 2013
Cutting Through the Biotech Stocks Hype / Companies / BioTech
By: Investment_U
Marc Lichtenfeld: When a woman, claiming to be the wife of a deceased general from Nigeria, writes to us saying she needs our help getting $10 million out of the country and in return we’ll get 20% of the money, most of us know that’s a load of bull.
But when the CEO of a publicly traded biotech company tells us his drug is the next great thing? How do we know if he’s being truthful, hopeful or just a plain scam artist?
Wednesday, December 04, 2013
The Best Shadow Investing Plays in Silicon Valley Tech Stocks Right Now / Companies / Tech Stocks
By: Money_Morning
Michael A. Robinson writes: This is one of the greatest secrets of investing.
It's a strategy that I developed during my 34 years in Silicon Valley. And it will let you tap into some big, big profits for a modest amount of effort.
In fact, this very cool approach to high-tech investing will uncover a bushel of double-digit winners that your friends, co-workers, and others you talk stocks with have no hopes of finding.
Read full article... Read full article...
Monday, December 02, 2013
Potash Undervalued Opportunity Ripe for Long-Term Investing / Companies / Potash
By: InvestmentContrarian
Sasha Cekerevac writes: As my long-time readers know, contrarian investing is all about buying when others are selling and selling when others are buying. Getting in ahead of the crowd is the key to successful long-term investing.
One market segment that has been severely hit over the past few months and could be ripe for long-term investing is the international potash market. Two firms operating out of Russia and Belarus essentially control approximately 40% of the potash market through a cartel that dictates supply and, ultimately, pricing.
Read full article... Read full article...